Alternative feed firm secures $30m funds

CALYSTA, the makers of Feedkind protein, have announced $30 million funding in a deal involving Cargill.

Also involved in the agreement were the Municipal Employee Retirement System (MERS) of Michigan and Old Westbury Global Real Assets Fund LLC.

Current Calysta investors, Walden Riverwood VenturesAqua-Spark and Pangaea Ventures, participated too.

Calysta intends to use the investment to advance new product development, commercial manufacturing and continued advances in its proprietary state-of-the-art gas fermentation platform.

With this funding, Brian Silvey, Cargill vice president, Corn Milling, and Edward Mikolay, MERS of Michigan senior investment officer and director of Private Markets, will be joining the Calysta board of directors.

In addition to the funding, Calysta and Cargill will collaborate in the North American manufacturing and global marketing of Calysta’s FeedKind protein, a family of high value environmentally friendly nutritional feed additives for fish and livestock.

‘This collaboration with Cargill, a world leader in fermentation and protein production, is expected to dramatically accelerate market introduction of FeedKind protein at commercial scale,’ said Alan Shaw (pictured), Calysta president and CEO.

‘We are also very pleased to add Bessemer and MERS, investors who bring a long term view of capital deployment, to Calysta’s distinguished group of investors.

‘Calysta is providing the aquaculture industry with a proprietary sustainable alternative to conventional fishmeal ingredients.

‘This in turn addresses the widely recognised concern about a worldwide shortage of protein, a serious potential threat to global food security.’

Cargill’s Silvey said: ‘Calysta brings key innovations in gas fermentation that complement Cargill’s global expertise in engineering, manufacturing and marketing.’

In January 2016 Calysta announced conditional receipt of a UK grant for development of a Market Introduction Facility in northern England. The UK facility is Calysta’s first research and market introduction facility for FeedKind protein.

 

 

Related Posts:

Comments are closed.